Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.
about
Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.Hypertension in Obesity and the Impact of Weight Loss.Emphasis on abdominal obesity as a modifier of eplerenone effect in heart failure: hypothesis-generating signals from EMPHASIS-HF.The selective mineralcorticoid receptor (MR) antagonist eplerenon prevents decompensation of liver cirrhosis.
P2860
Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preventive and chronic mineral ...... beneficial in obese SHHF rats.
@en
type
label
Preventive and chronic mineral ...... beneficial in obese SHHF rats.
@en
prefLabel
Preventive and chronic mineral ...... beneficial in obese SHHF rats.
@en
P2093
P2860
P356
P1476
Preventive and chronic mineral ...... beneficial in obese SHHF rats.
@en
P2093
P Lacolley
P2860
P304
P356
10.1111/BPH.13479
P407
P577
2016-03-16T00:00:00Z